Skip to main content
. 2014 Feb 5;34(6):2331–2348. doi: 10.1523/JNEUROSCI.2689-13.2014

Figure 7.

Figure 7.

ACM from SOD1G93A+ dnSNARE+ tTA+ astrocytes induces less ESMN death. A, Representative images of eGFP+ ESMNs treated with ACM from astrocytes with different genotypes. Scale bar, 40 μm. B, Percentage of surviving eGFP+ ESMNs treated with ACM collected from astrocytes with different genotypes. Total number of quantified ESMNs at the beginning of the treatment (day 1) is >200 per group from three to five independent experiments. *p < 0.05 by Student's t test.